bioMérieux S.A. Overview
Pro stress-test →bioMérieux is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, that provides diagnostic solutions (reagents, instruments, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. The company's products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies, as well as detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Strategic Profile
Pro stress-test →bioMérieux is a specialist in the fragmented in vitro diagnostics market with expertise in microbiology testing and syndromic molecular testing, positioning the company as a leader in niche markets that allows it to grow faster than the in vitro diagnostics market. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%).
Competitive Landscape
Pro stress-test →bioMérieux competes against 18 competitors including Bio-Rad Laboratories. The company's strength lies in niche market expertise rather than competing on volume, with specialized capabilities in microbiology, molecular diagnostics, and industrial contamination detection that differentiate it from larger generalist diagnostics players.
Industry Context
bioMérieux S.A. operates in In Vitro Diagnostics (IVD) / Clinical Laboratory Diagnostics.
Key facts
Founded: 1963 · Headquarters: Marcy-l'Étoile, France · Employees: 10000+ · Revenue: $4.48B · Market cap: $14.8B